Dha-structure (Dha)
Omega-3-acid Ethyl Esters Capsule, Liquid Filled
Product Images NDC 63629-1918
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Omega-3-acid Ethyl Esters (NDC 63629-1918). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Epa-structure (Epa)
Table-2 (Table 2)
This is a report of a clinical trial that compares the effects of Omega-3-acid ethyl esters versus placebo on blood lipid levels. The trial involved 42 participants and measured various parameters at baseline and after treatment. The results show a reduction in non-HDL-C levels and an increase in HDL-C levels in the Omega-3 group compared to the placebo group. However, other parameters such as TC, VLDL-C, and LDL-C did not show significant differences.*
Common Side Effects (Common Side Effects)
Label (Lbl636291918)
Description: These are Omega-3-Acid Ethyl Esters capsules containing 1g of USP per capsule. It is recommended to keep the medication away from children and to store it at a temperature between 20°C and 25°C. The capsules should be dispensed in a tightly sealed, light-resistant container with a child-resistant closure. The packaging contains 120 capsules and the product is available only on prescription.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
